SMI
11.695,38
PKT
-7,19
PKT
-0,06
%
Werbung
Analysen zu SMI-Werten
Datum | Rating | Analyst | |
---|---|---|---|
10.12.18 | Roche Hold | Deutsche Bank AG | |
10.12.18 | Novartis Hold | Deutsche Bank AG | |
10.12.18 | Novartis buy | Kepler Cheuvreux | |
10.12.18 | Novartis Underweight | Barclays Capital | |
10.12.18 | Holcim Underweight | Barclays Capital | |
10.12.18 | Zurich Insurance Neutral | JP Morgan Chase & Co. | |
10.12.18 | Nestlé overweight | JP Morgan Chase & Co. | |
10.12.18 | ABB (Asea Brown Boveri) buy | HSBC | |
10.12.18 | Givaudan Neutral | JP Morgan Chase & Co. | |
08.12.18 | Novartis Underweight | Barclays Capital | |
07.12.18 | ABB (Asea Brown Boveri) buy | Deutsche Bank AG | |
06.12.18 | Zurich Insurance Neutral | JP Morgan Chase & Co. | |
05.12.18 | ABB (Asea Brown Boveri) neutral | Morgan Stanley | |
05.12.18 | UBS Equal-Weight | Morgan Stanley | |
05.12.18 | Zurich Insurance overweight | JP Morgan Chase & Co. | |
05.12.18 | Roche overweight | JP Morgan Chase & Co. | |
05.12.18 | Holcim overweight | JP Morgan Chase & Co. | |
03.12.18 | Roche buy | Baader Bank | |
03.12.18 | Roche overweight | JP Morgan Chase & Co. | |
03.12.18 | Holcim buy | Deutsche Bank AG | |
03.12.18 | ABB (Asea Brown Boveri) Underweight | JP Morgan Chase & Co. | |
29.11.18 | UBS Outperform | Credit Suisse Group | |
28.11.18 | Novartis Neutral | JP Morgan Chase & Co. | |
28.11.18 | Novartis Hold | HSBC | |
28.11.18 | Holcim Neutral | UBS AG | |
28.11.18 | Holcim overweight | JP Morgan Chase & Co. | |
27.11.18 | Holcim overweight | JP Morgan Chase & Co. | |
27.11.18 | Swiss Re overweight | JP Morgan Chase & Co. | |
27.11.18 | Swiss Re buy | Deutsche Bank AG | |
27.11.18 | UBS overweight | Morgan Stanley | |
27.11.18 | UBS Equal-Weight | Morgan Stanley | |
27.11.18 | Givaudan Sell | Goldman Sachs Group Inc. | |
23.11.18 | ABB (Asea Brown Boveri) buy | Deutsche Bank AG | |
23.11.18 | UBS Sector Perform | RBC Capital Markets | |
23.11.18 | UBS Sector Perform | RBC Capital Markets | |
22.11.18 | Holcim Neutral | UBS AG | |
22.11.18 | UBS Underweight | Barclays Capital | |
21.11.18 | Novartis Neutral | UBS AG | |
20.11.18 | UBS buy | Deutsche Bank AG | |
20.11.18 | UBS Hold | Deutsche Bank AG |
* Die angezeigten Realtime Kurse sind indikativ und nicht die offiziellen Börsenkurse. Die Kursdaten können eventuell vom tatsächlichen Marktpreis abweichen.